Previous Article | Next Article 
Journal of Clinical Microbiology, June 1999, p. 1852-1857, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Nonisotopic Detection and Typing of Human
Papillomavirus DNA in Genital Samples by the Line Blot Assay
François
Coutlée,1,2,*
Patti
Gravitt,3,
Harriet
Richardson,4
Catherine
Hankins,4,5
Eduardo
Franco,4
Normand
Lapointe,1,6
Hélène
Voyer,2 and
The Canadian Women's HIV Study Group
Départements de
Microbiologie-Immunologie et de Pédiatrie, Université de
Montréal,1 Centre de Recherche et
Département de Microbiologie et Infectiologie, Centre Hospitalier
de l'Université de Montréal, Campus
Notre-Dame,2 Unité de Maladies
Infectieuses, Direction de la Santé Publique de
Montréal-Centre,5 Department
of Epidemiology and Biostatistics, McGill
University,4 and Centre Maternel et
Infantile sur le SIDA, Centre de Recherche de l'Hôpital
Sainte-Justine, Hôpital Sainte-Justine,6
Montréal, Québec, Canada, and Roche Molecular
Systems, Alameda, California3
Received 26 October 1998/Returned for modification 7 December
1998/Accepted 15 March 1999
The line blot assay, a gene amplification method that combines PCR
with nonisotopic detection of amplified DNA, was evaluated for its
ability to detect human papillomavirus (HPV) DNA in genital specimens.
Processed samples were amplified with biotin-labeled primers for HPV
detection (primers MY09, MY11, and HMB01) and for
-globin detection
(primers PC03 and PC04). Amplified DNA products were hybridized by a
reverse blot method with oligonucleotide probe mixtures fixed on a
strip that allowed the identification of 27 HPV genotypes. The line
blot assay was compared to a standard consensus PCR test in which HPV
amplicons were detected with radiolabeled probes in a dot blot assay.
Two hundred fifty-five cervicovaginal lavage specimens and cervical
scrapings were tested in parallel by both PCR tests. The line blot
assay consistently detected 25 copies of HPV type 18 per run. The
overall positivity for the DNA of HPV types detectable by both methods
was 37.7% (96 of 255 samples) by the line blot assay, whereas it was
43.5% (111 of 255 samples) by the standard consensus PCR assay. The
sensitivity and specificity of the line blot assay reached 84.7% (94 of 111 samples) and 98.6% (142 of 144 samples), respectively. The
agreement for HPV typing between the two PCR assays reached 83.9% (214 of 255 samples). Of the 37 samples with discrepant results, 33 (89%) were resolved by avoiding coamplification of
-globin and modifying the amplification parameters. With these modifications, the line blot
assay compared favorably to an assay that used radiolabeled probes. Its
convenience allows the faster analysis of samples for large-scale
epidemiological studies. Also, the increased probe spectrum in this
single hybridization assay permits more complete type discrimination.
*
Corresponding author. Mailing address:
Département de Microbiologie et Infectiologie, Centre Hospitalier
de l'Université de Montréal, Campus Notre-Dame, 1560 Sherbrooke est, Montréal, Québec H2L 4M1, Canada. Phone:
514-281-6000, ext. 5162. Fax: 514-896-4607. E-mail:
coutleef{at}sympatico.ca.
Present address: Department of Epidemiology, Johns Hopkins
University School of Hygiene and Public Health, Baltimore, MD 21205.

The Canadian Women's HIV study group includes the following
investigators: Catherine Hankins, Normand Lapointe, John Gill,
Barbara
Romanowski, Stephen Shafran, Rob Grimshaw, David Haase,
Wally Schlech,
Stephen Landis, John Sellors, Fiona Smaill, Francois
Beaudoin, Marc
Boucher, Ngoc Bui, Michel Chateauvert, Manon Coté,
François
Coutlée, Douglas Dalton, Gretty Deutsch, Julian Falutz,
Diane
Francoeur, Lisa Hallman, Lina Karayan, Louise Labrecque,
Richard
Lalonde, Christiane Lavoie, Catherine Lounsbury, John
Macleod, Nicole
Marceau, Grégoire Noel, Grégoire Piché, Jean-Pierre
Routy, Pierre Simard, Christina Smeja, Graham Smith, Pierre-Paul
Tellier, Emil Toma, Garry Garber, Garry Victor, Louise Coté,
Édith Guilbert, Michel Morissette, Hélène Senay,
Sylvie Trottier,
Phil Berger, Lisa Friedland, Donna Keystone, Joan
Murphy, Anne
Phillips, Marion Powell, Anita Rachlis, Pat Rockman,
Irving Salit,
Cheryl Wagner, Sharon Walmsey, Kurt Williams, Ian Bowmer,
Rory
Windrim, Roger Sandre, Penny Ballem, David Burdge, Brian Conway,
Marianne Harris, Deborah Money, Julio Montaner, and Janice
Veenhuizen.
Journal of Clinical Microbiology, June 1999, p. 1852-1857, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Coutlee, F., Rouleau, D., Ghattas, G., Hankins, C., Vezina, S., Cote, P., Macleod, J., de Pokomandy, A., Money, D., Walmsley, S., Voyer, H., Brassard, P., Franco, E.
(2007). Confirmatory Real-Time PCR Assay for Human Papillomavirus (HPV) Type 52 Infection in Anogenital Specimens Screened for HPV Infection with the Linear Array HPV Genotyping Test. J. Clin. Microbiol.
45: 3821-3823
[Abstract]
[Full Text]
-
Coutlee, F., Rouleau, D., Petignat, P., Ghattas, G., Kornegay, J. R., Schlag, P., Boyle, S., Hankins, C., Vezina, S., Cote, P., Macleod, J., Voyer, H., Forest, P., Walmsley, S., The Canadian Women's HIV Study Group, , Franco, E.
(2006). Enhanced Detection and Typing of Human Papillomavirus (HPV) DNA in Anogenital Samples with PGMY Primers and the Linear Array HPV Genotyping Test.. J. Clin. Microbiol.
44: 1998-2006
[Abstract]
[Full Text]
-
Huang, S.-L., Chao, A., Hsueh, S., Chao, F.-Y., Huang, C.-C., Yang, J.-E., Lin, C.-Y., Yan, C.-C., Chou, H.-H., Huang, K.-G., Huang, H.-J., Wu, T.-I, Tseng, M.-J., Qiu, J.-T., Lin, C.-T., Chang, T.-C., Lai, C.-H.
(2006). Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-Based Assay for Detection of Human Papillomavirus DNA in Cervical Swab Samples.. J. Clin. Microbiol.
44: 1733-1739
[Abstract]
[Full Text]
-
Richardson, H., Kelsall, G., Tellier, P., Voyer, H., Abrahamowicz, M., Ferenczy, A., Coutlee, F., Franco, E. L.
(2003). The Natural History of Type-specific Human Papillomavirus Infections in Female University Students. Cancer Epidemiol. Biomarkers Prev.
12: 485-490
[Abstract]
[Full Text]
-
Kornegay, J. R., Roger, M., Davies, P. O., Shepard, A. P., Guerrero, N. A., Lloveras, B., Evans, D., Coutlee, F.
(2003). International Proficiency Study of a Consensus L1 PCR Assay for the Detection and Typing of Human Papillomavirus DNA: Evaluation of Accuracy and Intralaboratory and Interlaboratory Agreement. J. Clin. Microbiol.
41: 1080-1086
[Abstract]
[Full Text]
-
Bosch, F X, Lorincz, A, Munoz, N, Meijer, C J L M, Shah, K V
(2002). The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol.
55: 244-265
[Abstract]
[Full Text]
-
van den Brule, A. J. C., Pol, R., Fransen-Daalmeijer, N., Schouls, L. M., Meijer, C. J. L. M., Snijders, P. J. F.
(2002). GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes. J. Clin. Microbiol.
40: 779-787
[Abstract]
[Full Text]
-
Coutlee, F., Gravitt, P., Kornegay, J., Hankins, C., Richardson, H., Lapointe, N., Voyer, H., Franco, E.
(2002). Use of PGMY Primers in L1 Consensus PCR Improves Detection of Human Papillomavirus DNA in Genital Samples. J. Clin. Microbiol.
40: 902-907
[Abstract]
[Full Text]
-
Kornegay, J. R., Shepard, A. P., Hankins, C., Franco, E., Lapointe, N., Richardson, H., Canadian Women's HIV Study Group, , Coutlee, F.
(2001). Nonisotopic Detection of Human Papillomavirus DNA in Clinical Specimens Using a Consensus PCR and a Generic Probe Mix in an Enzyme-Linked Immunosorbent Assay Format. J. Clin. Microbiol.
39: 3530-3536
[Abstract]
[Full Text]
-
Coutlée, F., de Ladurantaye, M., Tremblay, C., Vincelette, J., Labrecque, L., Roger, M.
(2000). An Important Proportion of Genital Samples Submitted for Chlamydia trachomatis Detection by PCR Contain Small Amounts of Cellular DNA as Measured by beta -Globin Gene Amplification. J. Clin. Microbiol.
38: 2512-2515
[Abstract]
[Full Text]
-
Vernon, S. D., Unger, E. R., Williams, D.
(2000). Comparison of Human Papillomavirus Detection and Typing by Cycle Sequencing, Line Blotting, and Hybrid Capture. J. Clin. Microbiol.
38: 651-655
[Abstract]
[Full Text]
-
Lacey, J. V. Jr., Brinton, L. A., Abbas, F. M., Barnes, W. A., Gravitt, P. E., Greenberg, M. D., Greene, S. M., Hadjimichael, O. C., McGowan, L., Mortel, R., Schwartz, P. E., Silverberg, S. G., Hildesheim, A.
(1999). Oral Contraceptives as Risk Factors for Cervical Adenocarcinomas and Squamous Cell Carcinomas. Cancer Epidemiol. Biomarkers Prev.
8: 1079-1085
[Abstract]
[Full Text]